Loading data for ADIL — first visit, this takes a few seconds.

アラート

Adial Pharmaceuticals Inc... (ADIL)

NasdaqCM: ADIL · リアルタイム株価 · USD

4.39

+0.08 (1.86%)

終値時点： Aug 18, 2026, 3:59 PM

5.45

+0.00%

寄り付き前: 6:34 AM

1.86% (1D)

買気配	4.57
時価総額	14.31M
売上高（TTM）	n/a
純利益（TTM）	-57.8M
ベータ	n/a
EPS（TTM）	-5.39
PER（TTM）	n/a
予想PER	-0.73
PBR（TTM）	-0.37
PSR（TTM）	n/a
Earnings Date	n/a

売気配	3.08
出来高	51,676
平均出来高（20日）	458,140
始値	4.35
前日終値	4.31
当日レンジ	4.26 - 4.63
52週レンジ	1.31 - 10.75
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

ADILについて

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The...

[続きを読む]

業種 Biotechnology

セクター Healthcare

IPO日 Jul 27, 2018

従業員数 5

上場取引所 NasdaqCM

ティッカー ADIL

ウェブサイト https://www.adial.com

企業情報の全文

業績

2025年のAdial Pharmaceuticalsの売上高は0で、前年の0からundefined%の増加でした。利益は-7.98Mで、-39.56%の減少でした。

財務諸表

決算サプライズ

Adial PharmaceuticalsはMay 8, 2026に四半期決算を発表しました：

売上高は $0 で、予想を下回りました $0, うち NaN% の前年比増加にあたります.

EPSは -1.48 で、予想を上回りました 0.77, うち 82.59% の前年比増加にあたります.

ニュース

2か月前 · MT Newswires

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index and the State Street

2か月前 · Stocktwits

ADIL Stock Eyes Best Day In Over 5 Years — Major Pipeline Overhaul And $64M Raise Fuel Rally

Adial on Thursday announced that it has bought privately held Azora Therapeutics.

7か月前 · Zacks

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.

10か月前 · The Fly

CoreWeave initiated, Instacart downgraded: Wall Street's top analyst calls

11か月前 · Benzinga

Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) on Tuesday received the final meeting minutes from its End of Phase 2 (EOP2) Meeting with the U.S. Food and Drug Administration (FDA) held in July. The minute...

2ページ中1ページ

Adial Pharmaceuticals Inc... (ADIL)